Stefan H. E. Kaufmann

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2021-11-25

Top Assignees for applications by Stefan H. E. Kaufmann

The entities that hold a legal rights for patent applications filed by inventor Kaufmann Stefan H. E.:

Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. 4 Munich, Germany
MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN e.V. 4 Muenchen, Germany
VAKZINE PROJEKT MANAGEMENT GMBH 3 Hannover, Germany
Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. 1 Munich, Germany
Seattle Children's Hospital 1 Seattle, WA United States
United Kingdom Research and Innovation 1 Swindon, United Kingdom
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. 1 Berlin, Germany
MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V 1 Muenchen, Germany
Max-Planck-Gesellschaft 1 Munich, Germany
Max-Planck-Gesellschaft zur Foerderung Der Wissenshaften e. V. 1 Munich, Germany
Max-Planck-Gesellschaft zur Foerderung der Wissenshaften, e.V. 1 Munich, Germany
STELLENBOSCH UNIVERSITY 1 Cape Town, South Africa
Medizinische Universität Wien 1 Wien, Germany
UNIVERSITY OF CAPE TOWN 1 Cape Town, South Africa
Medizinische Universitat Wien 1 Wien, Austria

Recent patent applications by Kaufmann Stefan H. E.

Stefan H. E. Kaufmann from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-11-25

US20210363580A1

Chemistry; metallurgy

Method for predicting progression to active tuberculosis disease

#2 | 2019-07-25

US20190226011A1

Chemistry; metallurgy

Methods for the detection of a latent tuberculosis infection

#3 | 2016-06-30

US20160184419A1

Human necessities

Recombinant as a vaccine

#4 | 2013-12-19

US20130337011A1

Chemistry; metallurgy

Recombinant mycobacterium as a vaccine

#5 | 2013-10-24

US20130280739A1

Physics

Determination of the efficacy of an anti-mycobacterial vaccination

#6 | 2012-02-02

US20120027794A1

Chemistry; metallurgy

Tuberculosis vaccine with improved efficacy

#7 | 2010-08-10

US9890339

Identification of specific differentially expressed antigens

#8 | 2008-11-13

US20080280848A1

Chemistry; metallurgy

Structures of Active Guide Rna Molecules and Method of Selection

#9 | 2007-06-14

US20070134267A1

Chemistry; metallurgy

Tuberculosis vaccine with improved efficacy

InventorID:

4292656 ⎘